Transcript Slide 1 - Emcdda

Communication and publications
Rosemary de Sousa, February 2008
We aim to provide a high-quality and highly
valued information service on the drugs
phenomenon in Europe
We communicate the results of the EMCDDA’s
monitoring and analytical work
We communicate this information to
• policy-makers and their advisors
• scientists and researchers
• practitioners and drug professionals
• the media and general public
How important is the EMCDDA's role in providing the
information needed by policy-makers?
Source: External evaluation of the EMCDDA, 2007
Context of current developments
• Communicating more effectively – priority in
2007–2009 strategy
• Updated communication strategy (endorsed
by Management Board in 2007)
• External evaluation conclusions and
recommendations
• 2008 work programme
Priorities for 2008
• Draw up action plan that makes balanced use of
existing communication channels
• Improve link between communication activities and
scientific work
• Reassess each output to see how it is meeting
audience needs
• Improve turnaround time of outputs and meet
minimum output targets
• Strengthen image and reputation as ‘EMCDDA – your
reference point on drugs in Europe’
Channels and tools used to communicate
•
•
•
•
•
•
Websites
Publications
Media relations and marketing
Participation in conferences
Events and representation work
Distribution
Overview of our
publications
Drugnet
Manuals
Annual report
Risk assessments
Insights
Monographs
Drugs in focus
Activities’ report
Thematic papers
Selected issues
Annual report process
Drug situation online
Drugnet Europe online
Country data profiles
Statistical bulletin
Drug profiles
Selected issues
How do you rate the quality of the various EMCDDA
publications and other information?
Source: External evaluation of the EMCDDA, 2007
Outputs due for release shortly
• GHB and its precursor GBL: an emerging trend case
study (Thematic paper)
• Substance use among older adults: a neglected
problem (Drugs in focus)
• A cannabis reader: global issues and local
experiences. Perspectives on cannabis
controversies, treatment and regulation in Europe
(Monograph)
• Prevention of substance abuse (Insights)
• Best practice portal
• General report of activities 2007
Outputs due for release before the summer
• Key indicator gateway
• Drug use, impaired driving and traffic accidents (Insights)
• Assessing illicit drugs in wastewater – prospects for a new
approach to monitoring drug use in the community (Insights)
• Heroin trafficking (Drugs in focus)
• Public expenditure (Selected issue)
• Drug profiles: hallucinogenic mushrooms, LSD, ketamine, GHB,
volatile substances
• Statistical bulletin
• Country situation summaries